🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/MMR
← Back to VaxIQ

MMR

Measles, Mumps, Rubella Vaccine

Tier 1 · EPI/CoreVaccineCuration in progress

Platform: Live attenuated viral (trivalent)

Combined vaccine that protects against measles, mumps, and rubella — three highly contagious viral diseases.

measlesmumpsrubellaherd immunitylive attenuated

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
MMR vaccine

The MMR vaccine is a combination vaccine against measles, mumps, and rubella. It contains the combined measles vaccine, mumps vaccine, and rubella vaccine into a single injection. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.